Radiation therapy for vulvar cancer: consensus guidelines of the GINECOR working group of the Spanish Society of Radiation Oncology. Part 1: clinical recommendations

[1]  P. Bhosale,et al.  Vulvar Cancer: 2021 Revised FIGO Staging System and the Role of Imaging , 2022, Cancers.

[2]  M. Beckmann,et al.  Adjuvant radiotherapy and local recurrence in vulvar cancer - a subset analysis of the AGO-CaRE-1 study. , 2021, Gynecologic oncology.

[3]  H. Putter,et al.  Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  J. Alcázar,et al.  Intraoperative electron beam radiotherapy and perioperative high-dose-rate brachytherapy in previously irradiated oligorecurrent gynecological cancer: clinical outcome analysis , 2021, Clinical and Translational Oncology.

[5]  B. Fionda,et al.  The role of brachytherapy (interventional radiotherapy) for primary and/or recurrent vulvar cancer: a Gemelli Vul.Can multidisciplinary team systematic review , 2021, Clinical and Translational Oncology.

[6]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[7]  N. Hacker,et al.  Radiotherapy is not indicated in patients with vulvar squamous cell carcinoma and only one occult intracapsular groin node metastasis. , 2020, Gynecologic oncology.

[8]  N. Bennion,et al.  Stereotactic body radiation therapy (SBRT) in recurrent, persistent or oligometastatic gynecological cancers. , 2020, Gynecologic oncology.

[9]  S. Jabbour,et al.  Stereotactic body radiation therapy for oligometastatic gynecologic malignancies: A systematic review. , 2020, Gynecologic oncology.

[10]  Longwen Chen,et al.  Tumor-free margins and local recurrence in squamous cell carcinoma of the vulva. , 2020, Gynecologic oncology.

[11]  R. Jach,et al.  Prognostic factors in patients with vulvar cancer: the VULCAN study , 2020, International Journal of Gynecological Cancer.

[12]  D. D'Souza,et al.  Stereotactic Ablative Radiotherapy for Recurrent or Metastatic Gynecological Cancer: Extending Lives? , 2020, Current Treatment Options in Oncology.

[13]  A. Gadducci,et al.  Locally advanced squamous cell carcinoma of the vulva: A challenging question for gynecologic oncologists. , 2020, Gynecologic oncology.

[14]  C. Touboul,et al.  Patterns of first recurrence and outcomes in surgically treated women with vulvar cancer: results from FRANCOGYN study group. , 2020, Journal of gynecology obstetrics and human reproduction.

[15]  B. Yaremko,et al.  Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial , 2020, medRxiv.

[16]  José Raúl Rodríguez Rodríguez,et al.  Geriatría transversal. Un reto asistencial para el siglo xxi , 2020 .

[17]  M. Vidán,et al.  [Cross-speciality geriatrics: A health-care challenge for the 21st century]. , 2019, Revista espanola de geriatria y gerontologia.

[18]  R. Wenham,et al.  High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: Outcome and toxicity. , 2019, Gynecologic oncology.

[19]  C. Touboul,et al.  Inguino-femoral radiotherapy in vulvar squamous cell carcinoma: clues to revised indications in patients with only one intracapsular lymph node metastasis , 2019, Acta oncologica.

[20]  C. Touboul,et al.  Surgical treatment of vulvar cancer: Impact of tumor-free margin distance on recurrence and survival. A multicentre cohort analysis from the francogyn study group. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  T. Fehm,et al.  Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study. , 2019, Gynecologic oncology.

[22]  P. Hillemanns,et al.  Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study. , 2019, Gynecologic oncology.

[23]  H. Hollema,et al.  Margin status revisited in vulvar squamous cell carcinoma. , 2019, Gynecologic oncology.

[24]  E. Sartori,et al.  Multivariate analysis of prognostic factors in primary squamous cell vulvar cancer: The role of perineural invasion in recurrence and survival. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[25]  Michael Lock,et al.  Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial , 2019, The Lancet.

[26]  G. Cohen,et al.  The American Brachytherapy Society consensus statement on intraoperative radiation therapy. , 2019, Brachytherapy.

[27]  S. Salvador,et al.  No. 370-Management of Squamous Cell Cancer of the Vulva. , 2019, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[28]  B. Pitcher,et al.  Perineural invasion (PNI) in vulvar carcinoma: A review of 421 cases. , 2019, Gynecologic oncology.

[29]  N. Rydzewski,et al.  Role of adjuvant external beam radiotherapy and chemotherapy in one versus two or more node-positive vulvar cancer: A National Cancer Database study. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  Yang Zhang,et al.  Prevalence of human papillomavirus and its prognostic value in vulvar cancer: A systematic review and meta-analysis , 2018, PloS one.

[31]  F. Zlámal,et al.  Vulvar cancer recurrence - an analysis of prognostic factors in tumour-free pathological margins patients group. , 2018, Ginekologia polska.

[32]  F. Demirkıran,et al.  The Role of Pathological Margin Distance and Prognostic Factors After Primary Surgery in Squamous Cell Carcinoma of the Vulva , 2018, International Journal of Gynecologic Cancer.

[33]  P. Grigsby,et al.  Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database. , 2017, Gynecologic oncology.

[34]  F. Ghezzi,et al.  Predictors and Patterns of Local, Regional, and Distant Failure in Squamous Cell Carcinoma of the Vulva , 2017, American journal of clinical oncology.

[35]  C. Haie-meder,et al.  Brachytherapy as part of the conservative treatment for primary and recurrent vulvar carcinoma. , 2017, Brachytherapy.

[36]  Julian C. Hong,et al.  Primary Versus Preoperative Radiation for Locally Advanced Vulvar Cancer , 2017, International Journal of Gynecologic Cancer.

[37]  R. Rouzier,et al.  European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer , 2017, International Journal of Gynecologic Cancer.

[38]  L. Verleye,et al.  Locally advanced vulva cancer: A single centre review of anovulvectomy and a systematic review of surgical, chemotherapy and radiotherapy alternatives. Is an international collaborative RCT destined for the "too difficult to do" box? , 2017, Gynecologic oncology.

[39]  T. Fehm,et al.  Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study. , 2016, European journal of cancer.

[40]  S. Kehoe,et al.  Adjacent Lichen Sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma. , 2016, Gynecologic oncology.

[41]  T. Stijnen,et al.  Tumour-free margins in vulvar squamous cell carcinoma: Does distance really matter? , 2016, European journal of cancer.

[42]  F. Lucas,et al.  Biomarkers p16, Human Papillomavirus and p53 Predict Recurrence and Survival in Early Stage Squamous Cell Carcinoma of the Vulva , 2016, Journal of lower genital tract disease.

[43]  D. Provencher,et al.  Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. , 2016, Gynecologic oncology.

[44]  S. Kellas-Ślęczka,et al.  Interstitial high-dose-rate brachytherapy in locally advanced and recurrent vulvar cancer , 2016, Journal of contemporary brachytherapy.

[45]  T. Ignatov,et al.  Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins , 2016, Journal of Cancer Research and Clinical Oncology.

[46]  C. Faloppa,et al.  How important is the pathological margin distance in vulvar cancer? , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[47]  N. Hacker,et al.  Cancer of the vulva , 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[48]  S. Post,et al.  Perineural Invasion Is an Independent Pathologic Indicator of Recurrence in Vulvar Squamous Cell Carcinoma , 2015, The American journal of surgical pathology.

[49]  M. Rajagopalan,et al.  Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis. , 2015, Gynecologic oncology.

[50]  P. Hillemanns,et al.  Adjuvant Therapy in Lymph Node–Positive Vulvar Cancer: The AGO-CaRE-1 Study , 2015, Journal of the National Cancer Institute.

[51]  A. Aragona,et al.  Defining the concept of locally advanced squamous cell carcinoma of the vulva: a new perspective based on standardization of criteria and current evidence , 2014, Journal of gynecologic oncology.

[52]  P. Jacobsen,et al.  Geriatric oncology: an overview. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  R. Berkowitz,et al.  Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. , 2013, Gynecologic oncology.

[54]  Elie A Akl,et al.  GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. , 2013, Journal of clinical epidemiology.

[55]  S. Waggoner,et al.  Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies , 2012, Front. Oncol..

[56]  L. Woelber,et al.  Prognostic Role of Lymph Node Metastases in Vulvar Cancer and Implications for Adjuvant Treatment , 2012, International Journal of Gynecologic Cancer.

[57]  T. Lawrie,et al.  Primary groin irradiation versus primary groin surgery for early vulvar cancer. , 2011, The Cochrane database of systematic reviews.

[58]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[59]  Howard Balshem,et al.  GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.

[60]  H. Michael,et al.  A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. , 2011, Gynecologic oncology.

[61]  Xu Xi,et al.  To Be American , 2011, Fourth Genre: Explorations in Nonfiction.

[62]  H. Hollema,et al.  Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. , 2010, The Lancet. Oncology.

[63]  C. Tian,et al.  Radiation Therapy Compared With Pelvic Node Resection for Node-Positive Vulvar Cancer: A Randomized Controlled Trial , 2009, Obstetrics and gynecology.

[64]  L. Stalpers,et al.  Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial. , 2009, Gynecologic oncology.

[65]  J. Berek,et al.  The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. , 2006, Gynecologic oncology.

[66]  J. Alcázar,et al.  PERIOPERATIVE HIGH DOSE RATE BRACHYTHERAPY IN LOCALLY ADVANCED AND RECURRENT GYNECOLOGICAL CANCER , 2004, International Journal of Gynecologic Cancer.

[67]  M. Hoffman.  Squamous-cell carcinoma of the vulva: locally advanced disease. , 2003, Best practice & research. Clinical obstetrics & gynaecology.

[68]  G. Montana,et al.  Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. , 2000, International journal of radiation oncology, biology, physics.

[69]  F. Hasson,et al.  Research guidelines for the Delphi survey technique. , 2000, Journal of advanced nursing.

[70]  A. Gadducci,et al.  Patterns of recurrence in patients with squamous cell carcinoma of the vulva , 2000, Cancer.

[71]  G. Montana,et al.  Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. , 1998, International journal of radiation oncology, biology, physics.

[72]  É. Luporsi,et al.  Effectiveness of brachytherapy in treating carcinoma of the vulva. , 1995, International journal of radiation oncology, biology, physics.

[73]  M. Sideri,et al.  Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. , 1992, Gynecologic oncology.

[74]  N. Hacker,et al.  Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. , 1990 .

[75]  B. Bundy,et al.  Radiation Therapy Versus Pelvic Node Resection for Carcinoma of the Vulva With Positive Groin Nodes , 1986, Obstetrics and gynecology.

[76]  S. Shrivastava,et al.  Clinical outcome of high-dose-rate interstitial brachytherapy in vulvar cancer: A single institutional experience. , 2017, Brachytherapy.

[77]  D. Provencher,et al.  Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. , 2016, Gynecologic oncology.

[78]  M. Fabrini,et al.  Radiotherapy as Definitive Treatment of Patients with Primary Vulvar Carcinoma Unfit for Surgery and with Recurrent Vulvar Carcinoma After Primary Radical Surgery: Results of a Retrospective Single-center Study. , 2016, Anticancer research.

[79]  R. Kurman,et al.  WHO classification of tumours of female reproductive organs , 2014 .

[80]  Hodgkin Lymphoma.  NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines , 2014 .

[81]  L. Rubenstein,et al.  Comprehensive geriatric assessment: Toward understanding its efficacy , 1989, Aging.